IRIS Accounts Production v25.1.4.42 10637955 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh106379552024-03-31106379552025-03-31106379552024-04-012025-03-31106379552023-03-31106379552023-04-012024-03-31106379552024-03-3110637955ns15:EnglandWales2024-04-012025-03-3110637955ns14:PoundSterling2024-04-012025-03-3110637955ns10:Director12024-04-012025-03-3110637955ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3110637955ns10:SmallEntities2024-04-012025-03-3110637955ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3110637955ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3110637955ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3110637955ns10:FullAccounts2024-04-012025-03-3110637955ns10:Director22024-04-012025-03-3110637955ns10:RegisteredOffice2024-04-012025-03-3110637955ns5:CurrentFinancialInstruments2025-03-3110637955ns5:CurrentFinancialInstruments2024-03-3110637955ns5:Non-currentFinancialInstruments2025-03-3110637955ns5:Non-currentFinancialInstruments2024-03-3110637955ns5:ShareCapital2025-03-3110637955ns5:ShareCapital2024-03-3110637955ns5:RetainedEarningsAccumulatedLosses2025-03-3110637955ns5:RetainedEarningsAccumulatedLosses2024-03-3110637955ns5:PlantMachinery2024-04-012025-03-3110637955ns5:PlantMachinery2024-03-3110637955ns5:PlantMachinery2025-03-3110637955ns5:PlantMachinery2024-03-3110637955ns5:CurrentFinancialInstrumentsns5:WithinOneYear2025-03-3110637955ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-31
REGISTERED NUMBER: 10637955 (England and Wales)


















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

FOR

AVENUEBIO CONSULTING LTD

AVENUEBIO CONSULTING LTD (REGISTERED NUMBER: 10637955)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


AVENUEBIO CONSULTING LTD

COMPANY INFORMATION
for the Year Ended 31 March 2025







DIRECTORS: M Craig
Mrs J J Craig





REGISTERED OFFICE: Highlands
Boundary Road
Dockenfield
Surrey
GU10 4EU





REGISTERED NUMBER: 10637955 (England and Wales)






AVENUEBIO CONSULTING LTD (REGISTERED NUMBER: 10637955)

BALANCE SHEET
31 March 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 101,775 103,446

CURRENT ASSETS
Debtors 5 1,765,529 1,068,126
Investments 6 (3,283 ) -
Cash at bank 1,503,179 1,120,129
3,265,425 2,188,255
CREDITORS
Amounts falling due within one year 7 961,187 963,513
NET CURRENT ASSETS 2,304,238 1,224,742
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,406,013

1,328,188

CREDITORS
Amounts falling due after more than one
year

8

(21,477

)

(41,652

)

PROVISIONS FOR LIABILITIES (25,444 ) (25,860 )
NET ASSETS 2,359,092 1,260,676

CAPITAL AND RESERVES
Called up share capital 3 3
Retained earnings 2,359,089 1,260,673
SHAREHOLDERS' FUNDS 2,359,092 1,260,676

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

AVENUEBIO CONSULTING LTD (REGISTERED NUMBER: 10637955)

BALANCE SHEET - continued
31 March 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 June 2025 and were signed on its behalf by:





M Craig - Director


AVENUEBIO CONSULTING LTD (REGISTERED NUMBER: 10637955)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

AvenueBio Consulting Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance and 25% on cost

Fixed assets are stated at their cost prices, less accumulated depreciation and amounts recognised in respect of impairment.

Investments
Investments relate to an investment in an unlisted entity which is stated at cost less impairment. At each balance sheet date, the investment is assessed for indicators of impairment and where there are indicators of impairment, recoverable amount is assessed. If recoverable amount is less than carrying amount, the investment is written down to recoverable amount by way of an impairment loss which is recognised in profit or loss.

Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment.
Debtors and creditors that fall due within one year are recorded in the financial statements at transaction price and then subsequently measured at amortised cost. If the effects of the time value of money are immaterial, they are measured at cost (less impairment for trade debtors). Debtors are reviewed for impairment at each reporting date and any impairments are recorded within profit or loss and shown within administrative expenses when there is objective evidence that a debtor is impaired. Objective evidence that a debtor is impaired arises when the customer is unable to settle amounts owing to the company or the customer becomes bankrupt. Debtors do not carry interest and are stated at their nominal value. Trade creditors are not interest-bearing and are stated at their nominal value.
Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognized in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset which exceeds what the carrying amount would have been had the impairment loss not previously been recognised.


AVENUEBIO CONSULTING LTD (REGISTERED NUMBER: 10637955)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2025

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 24 (2024 - 16 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2024 170,028
Additions 31,253
At 31 March 2025 201,281
DEPRECIATION
At 1 April 2024 66,582
Charge for year 32,924
At 31 March 2025 99,506
NET BOOK VALUE
At 31 March 2025 101,775
At 31 March 2024 103,446

Tangible fixed assets include assets acquired under hire purchase agreements. At the balance sheet date, the cost of these assets was £62,180 (2024: £62,180), with accumulated depreciation of £23,317.50 (2024: £10,363.33), resulting in a net book value of £38,862.50 (2024: £51,816.67). These assets are depreciated over the shorter of the hire purchase term and their estimated useful economic lives. The corresponding hire purchase liabilities are included within creditors.

AVENUEBIO CONSULTING LTD (REGISTERED NUMBER: 10637955)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2025

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 543,371 732,366
Other debtors 1,222,158 335,760
1,765,529 1,068,126

6. CURRENT ASSET INVESTMENTS
2025 2024
£    £   
Unlisted investments (3,283 ) -

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 7,134 6,953
Hire purchase contracts 13,041 12,004
Trade creditors 141,227 60,600
Taxation and social security 423,623 548,889
Other creditors 376,162 335,067
961,187 963,513

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Bank loans 1,227 8,362
Hire purchase contracts 20,250 33,290
21,477 41,652

9. OTHER FINANCIAL COMMITMENTS

Total financial commitments, guarantees and contingencies which are not included in the balance sheet amount to £145,228 (2024: £44,845) and are in relation to commitments under operating leases.